First Tracks Biotherapeutics Inc (TRAX) Price Prediction & ForecastTRAXFirst Tracks Biotherapeutics Inc

Alphio's TRAX stock price prediction model matches the current First Tracks Biotherapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $41.77 (-2.34%). The 1-week path is $43.60 (+1.93%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

First Tracks Biotherapeutics, Inc. (TRAX) appears to be a good buy right now due to its current price of $34.46, which is significantly below the analyst price target of $70, suggesting a potential upside of 103%. Additionally, the stock has shown a year-to-date change of +53.09%, indicating strong performance. The upcoming release of top-line data from the ANB033 study could further enhance investor sentiment and drive the stock price higher. However, the main risk is the company's negative earnings per share (EPS) of -0.95 reported in the last quarter, which reflects ongoing financial challenges.

First Tracks Biotherapeutics Inc (TRAX) last closed at $42.77, gaining +3.68%. These facts feed the 1-day and 1-week TRAX price prediction above.